Financial Snapshot

Revenue
$2.041M
TTM
Gross Margin
75.67%
TTM
Net Earnings
-$2.757M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
1.79%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$12.55M
Q3 2024
Cash
Q3 2024
P/E
-1.002
Nov 29, 2024 EST
Free Cash Flow
-$1.460M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $4.347M $4.896M $6.555M $2.051M $376.0K $520.8K $170.7K $80.81K $158.2K $251.8K
YoY Change -11.21% -25.31% 219.6% 445.48% -27.8% 205.05% 111.25% -48.92% -37.18%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $4.347M $4.896M $6.555M $2.051M $376.0K $520.8K $170.7K $80.81K $158.2K $251.8K
Cost Of Revenue $1.238M $1.557M $2.173M $1.076M $231.0K $279.9K $180.6K $153.3K $117.0K $205.1K
Gross Profit $3.109M $3.339M $4.382M $975.0K $145.0K $240.8K -$9.920K -$72.52K $41.20K $46.71K
Gross Profit Margin 71.52% 68.2% 66.85% 47.54% 38.56% 46.25% -5.81% -89.74% 26.04% 18.55%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Selling, General & Admin $9.120M $11.73M $18.88M $11.37M $10.12M $6.453M $5.915M $3.104M $920.3K $914.7K
YoY Change -22.22% -37.9% 66.12% 12.31% 56.81% 9.11% 90.56% 237.27% 0.6%
% of Gross Profit 293.34% 351.15% 430.85% 1165.64% 6978.62% 2679.53% 2233.62% 1958.34%
Research & Development $0.00 $492.0K $2.369M $2.789M $2.308M $1.409M $1.427M $753.4K $681.7K $663.9K
YoY Change -100.0% -79.23% -15.06% 20.84% 63.85% -1.31% 89.46% 10.51% 2.68%
% of Gross Profit 0.0% 14.73% 54.06% 286.05% 1591.72% 584.89% 1654.61% 1421.32%
Depreciation & Amortization $1.000K $1.000K $200.0K $200.0K $577.0K $149.8K $164.6K $172.6K $157.6K $151.2K
YoY Change 0.0% -99.5% 0.0% -65.34% 285.18% -8.99% -4.64% 9.56% 4.2%
% of Gross Profit 0.03% 0.03% 4.56% 20.51% 397.93% 62.2% 382.4% 323.7%
Operating Expenses $8.615M $21.61M $19.47M $19.93M $14.08M $7.862M $7.342M $3.857M $1.602M $1.579M
YoY Change -60.13% 10.96% -2.3% 41.53% 79.15% 7.08% 90.35% 140.77% 1.48%
Operating Profit -$5.506M -$18.27M -$15.09M -$18.96M -$13.94M -$7.621M -$7.352M -$3.930M -$1.561M -$1.532M
YoY Change -69.86% 21.06% -20.39% 36.01% 82.91% 3.66% 87.09% 151.78% 1.88%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Interest Expense $44.00K $44.00K $544.0K $2.472M -$3.527M -$3.267M -$840.1K -$121.1K -$173.3K -$84.84K
YoY Change 0.0% -91.91% -77.99% -170.09% 7.97% 288.85% 593.52% -30.09% 104.22%
% of Operating Profit
Other Income/Expense, Net $2.065M -$228.0K $1.899M -$11.66M -$575.0K $393.4K $30.83K -$106.8K $105.7K -$32.48K
YoY Change -1005.7% -112.01% -116.28% 1928.35% -246.16% 1176.06% -128.87% -200.99% -425.52%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Pretax Income -$3.441M -$18.50M -$13.19M -$30.62M -$21.37M -$10.43M -$8.164M -$4.157M -$1.603M -$664.8K
YoY Change -81.4% 40.21% -56.92% 43.27% 104.9% 27.77% 96.36% 159.35% 141.12%
Income Tax -$3.000K $42.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.444M -$25.51M -$13.19M -$30.62M -$21.36M -$10.40M -$8.150M -$4.157M -$1.603M -$664.8K
YoY Change -86.5% 93.35% -56.92% 43.34% 105.41% 27.61% 96.03% 159.35% 141.12%
Net Earnings / Revenue -79.23% -521.02% -201.27% -1492.98% -5681.65% -1997.2% -4774.11% -5144.76% -1013.25% -264.0%
Basic Earnings Per Share -$0.26 -$0.65
Diluted Earnings Per Share -$0.05 -$0.36 -$0.26 -$0.65 -$618.5K -$416.0K -$344.6K -$457.0K -$241.8K -$28.57K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash & Short-Term Investments $49.00K $2.943M $16.00K $1.725M $4.096M $501.0K $108.3K $1.106M $13.35K $4.210K
YoY Change -98.34% 18293.75% -99.07% -57.89% 717.63% 362.78% -90.21% 8185.69% 217.1%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $286.0K $441.0K $544.0K $1.452M $1.794M $946.4K $586.9K $223.9K $88.10K $44.24K
YoY Change -35.15% -18.93% -62.53% -19.06% 89.56% 61.26% 162.14% 154.12% 99.14%
Inventory $199.0K $145.0K $864.0K $449.0K $156.0K $37.78K $45.00K $81.29K $191.5K $178.5K
Prepaid Expenses
Receivables $443.0K $232.0K $357.0K $224.0K $142.0K $102.8K $4.360K $7.050K $19.86K $114.8K
Other Receivables $979.0K $2.167M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $1.956M $5.928M $1.781M $3.850M $6.188M $1.588M $744.5K $1.418M $312.8K $341.7K
YoY Change -67.0% 232.85% -53.74% -37.78% 289.69% 113.29% -47.51% 353.48% -8.47%
Property, Plant & Equipment $54.00K $164.0K $2.138M $2.469M $704.0K $299.9K $337.4K $370.7K $381.8K $311.7K
YoY Change -67.07% -92.33% -13.41% 250.71% 134.74% -11.1% -8.98% -2.93% 22.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $264.0K $411.0K $216.0K $509.0K $259.0K
YoY Change -35.77% 90.28% -57.56% 96.53%
Other Assets $36.00K $36.00K $83.00K $58.00K $35.00K $595.5K $117.6K $151.6K $177.8K $286.2K
YoY Change 0.0% -56.63% 43.1% 65.71% -94.12% 406.53% -22.44% -14.76% -37.87%
Total Long-Term Assets $651.0K $926.0K $38.79M $42.51M $26.27M $1.808M $1.355M $1.417M $1.509M $1.523M
YoY Change -29.7% -97.61% -8.74% 61.8% 1352.96% 33.41% -4.33% -6.14% -0.89%
Total Assets $2.607M $6.854M $40.57M $46.36M $32.46M $3.396M $2.100M $2.835M $1.822M $1.865M
YoY Change
Accounts Payable $2.452M $1.065M $2.848M $2.135M $1.260M $774.4K $545.0K $265.4K $614.3K $322.7K
YoY Change 130.23% -62.61% 33.4% 69.44% 62.71% 42.1% 105.35% -56.79% 90.36%
Accrued Expenses $1.387M $1.709M $3.857M $1.392M $223.0K $508.7K $130.0K $26.31K $297.9K $272.3K
YoY Change -18.84% -55.69% 177.08% 524.22% -56.17% 291.39% 394.03% -91.17% 9.4%
Deferred Revenue
YoY Change
Short-Term Debt $139.0K $711.0K $3.662M $2.220M $727.0K $6.268M $2.402M $83.28K $832.3K $67.19K
YoY Change -80.45% -80.58% 64.95% 205.36% -88.4% 160.94% 2784.14% -89.99% 1138.68%
Long-Term Debt Due $8.099M $9.180M $11.96M $7.726M $11.00K $0.00 $9.450K $3.126M $0.00
YoY Change -11.78% -23.22% 54.75% 70136.36% -100.0% -99.7%
Total Short-Term Liabilities $12.49M $13.91M $24.26M $14.47M $11.84M $8.552M $3.529M $558.0K $5.086M $1.511M
YoY Change -10.21% -42.65% 67.7% 22.23% 38.41% 142.32% 532.4% -89.03% 236.56%
Long-Term Debt $0.00 $0.00 $27.00K $7.050M $52.00K $0.00 $0.00 $0.00 $9.450K $2.384M
YoY Change -100.0% -99.62% 13457.69% -100.0% -99.6%
Other Long-Term Liabilities $0.00 $46.00K $174.0K $3.563M $7.065M $0.00 $560.0K $560.0K $560.0K $200.0K
YoY Change -100.0% -73.56% -95.12% -49.57% -100.0% 0.0% 0.0% 180.0%
Total Long-Term Liabilities $0.00 $46.00K $201.0K $10.61M $7.117M $0.00 $560.0K $560.0K $569.5K $2.584M
YoY Change -100.0% -77.11% -98.11% 49.12% -100.0% 0.0% -1.66% -77.96%
Total Liabilities $12.49M $13.96M $24.46M $25.08M $18.95M $8.568M $4.136M $1.118M $5.656M $4.095M
YoY Change -10.5% -42.94% -2.46% 32.33% 121.21% 107.16% 269.93% -80.23% 38.11%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Basic Shares Outstanding 50.18M shares 47.31M shares
Diluted Shares Outstanding 50.18M shares 47.31M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.7624 Million

About Avenir Wellness Solutions, Inc.

Avenir Wellness Solutions, Inc. is a biopharmaceutical company, which engages in the development and manufacture of drug formulation and drug delivery technologies in novel dosage forms to improve drug safety and patient adherence. The company is headquartered in Sherman Oaks, California and currently employs 11 full-time employees. The company went IPO on 2016-05-11. The firm develops proprietary wellness, nutraceutical, and topical delivery systems. The firm is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Company’s wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The firm sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.

Industry: Pharmaceutical Preparations Peers: Context Therapeutics Inc. JOHNSON & JOHNSON KALA BIO, Inc. LANNETT CO INC MJ Holdings, Inc. OTONOMY, INC. Traws Pharma, Inc. TITAN PHARMACEUTICALS INC